Impact of Programmed Death Ligand 1 Expression in Advanced Non-Small–Cell Lung Cancer Patients, Treated by Chemotherapy (GFPC 06-2015 Study)

Overview of attention for article published in OncoTargets and therapy, December 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 12 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 792 followers.

Impact of Programmed Death Ligand 1 Expression in Advanced Non-Small–Cell Lung Cancer Patients, Treated by Chemotherapy (GFPC 06-2015 Study) https://t.co/K1WUaxCGpk

05 Mar 2021

Reply Repost Favourite

Impact of Programmed Death Ligand 1 Expression in Advanced Non-Small013Cell Lung Cancer Patients, Treated ... https://t.co/K1WUaxCGpk

20 Jan 2021

Reply Repost Favourite

Dove Medical Press

Article Metrics

Impact of Programmed Death Ligand 1 Expression in Advanced Non-Small–Cell Lung Cancer Patients, Treated by Chemotherapy (GFPC 06-2015 Study)

Mentioned by

Citations

Readers on